| abstract |
The present invention provides a compound of formula (I) and its split enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof: n (I) n AL-CR n Wherein CR is a cyclic core group, L is a linking group, and A is as defined herein. Also provided are methods of using the compounds of the invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. n n Protein kinases, AKT, hyperproliferative diseases |